IQVIA LRx France and Italy are two nationwide prescription databases, with 47% coverage of pharmacies and 70% coverage of reimbursed prescriptions in retail, respectively [12]
Bank of Americas Alexander Perry held a Buy rating on Planet Fitness with a $75 price target as early as November 7, 2023, citing early signs of benefits to fitness industry from increased usage of GLP-1 drugs. BMOs Simeon Siegel was telling reporters that in a world where GLP-1s become widely accessible, gyms from Planet Fitness all the way up to the highest-end brands are likely going to pull out marketing campaigns looking to boost their membership bases. But the bullish notes were swimming against the tape
The rise of obesity and associated health risks has led to the exploration of effective treatment options, with Semaglutide and Tirzepatide standing out as two leading injectable medications for managing weight
Though compounded semaglutide may fill a need during the shortage, you may not experience the same results
Yes, semaglutide can kickstart weight loss and help you keep it off long-term
